The Covid-19 pandemic has partially crippled the world as we once knew it. Everyone has experienced taking precautions, isolating, vaccinations, and boosters for over two years. Are we making progress?

The contagious virus SARS-CoV-2, also named Covid-19, has been responsible for over 970,000 deaths in the United States alone. New variants have emerged from the virus, but there appear to be fewer cases overall.

Pfizer-BioNTech and Moderna have been the leading pharmaceutical companies providing preventative vaccinations and vaccine boosters, and Johnson & Johnson has also joined the team for preventive immunizations.

The immunizations and boosters administered have been very effective even though there have been breakthroughs of covid-positive cases. The hospitalization of those patients who tested positive for Covid-19 reduced drastically for the fully vaccinated adults.

This year, both Pfizer and Moderna have requested authorization from the U.S. Food and Drug Administration (FDA) for an additional booster to their immunization. The requests were based on the success of the second booster in other countries. The goal is to offer maximum protection to high-risk patients–including adults over the age of 65 and adults with immune-suppressive medical conditions.

The best way anyone can reduce their risk of getting the disease is by getting Covid-19 vaccinations and all the boosters available. The Center for Disease Control’s consistent message to stay healthy continues to be to wear masks in highly populated indoor locations, keep at least 6 feet from others, avoid heavy crowds, and wash our hands.

The Center for Disease Control (CDC) still requires face masks on public transportation like buses, planes, and trains. Because of our advancements in the Covid-19 battle, many state legislations have lifted the face mask requirements for restaurants and shopping.